Alliance Wealth Advisors (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Alliance Wealth Advisors (Pennsylvania)'s BMY Position: Q2 2026 in Review
Alliance Wealth Advisors (Pennsylvania) reduced its Bristol-Myers Squibb (BMY) stake by 3.3% in Q2 2026, selling an estimated $7K and leaving 3,603 shares worth $208K. The position accounts for 0.07% of the portfolio, ranked #164.
Alliance Wealth Advisors (Pennsylvania) first reported a position in BMY in Q4 2020 and has held it in 17 quarters since. The position peaked at $481K in Q4 2020. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Alliance Wealth Advisors (Pennsylvania) held 3,603 shares of Bristol-Myers Squibb worth $208K as of Q2 2026.
- Alliance Wealth Advisors (Pennsylvania) sold 122 Bristol-Myers Squibb shares in Q2 2026, an estimated $7K.
- Bristol-Myers Squibb made up 0.07% of Alliance Wealth Advisors (Pennsylvania)'s portfolio in Q2 2026, its #164 holding.
- Alliance Wealth Advisors (Pennsylvania) first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 17 quarters since.
- Alliance Wealth Advisors (Pennsylvania)'s Bristol-Myers Squibb position peaked at $481K in Q4 2020.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Alliance Wealth Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 9 Jul 2026.